Unknown

Dataset Information

0

Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort.


ABSTRACT: An effective vaccine against the dengue virus (DENV) should induce a balanced, long-lasting antibody (Ab) response against all four viral serotypes. The burst of plasmablasts in the peripheral blood after vaccination may reflect enriched vaccine-specific Ab secreting cells. Here we characterize the acute plasmablast responses from naïve and DENV-exposed individuals following immunization with the live attenuated tetravalent (LAT) Butantan DENV vaccine (Butantan-DV). The frequency of circulating plasmablasts was determined by flow cytometric analysis of fresh whole blood specimens collected from 40 participants enrolled in the Phase II Butantan-DV clinical trial (NCT01696422) before and after (days 6, 12, 15 and 22) vaccination. We observed a peak in the number of circulating plasmablast at day 15 after vaccination in both the DENV naïve and the DENV-exposed vaccinees. DENV-exposed vaccinees experienced a significantly higher plasmablast expansion. In the DENV-naïve vaccinees, plasmablasts persisted for approximately three weeks longer than among DENV-exposed volunteers. Our findings indicate that the Butantan-DV can induce plasmablast responses in both DENV-naïve and DENV-exposed individuals and demonstrate the influence of pre-existing DENV immunity on Butantan DV-induced B-cell responses.

SUBMITTER: Silveira CGT 

PROVIDER: S-EPMC9274664 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6392503 | biostudies-literature
2016-05-10 | GSE72430 | GEO
| S-EPMC7762770 | biostudies-literature
| S-EPMC6356269 | biostudies-literature
| S-EPMC4621245 | biostudies-literature
| S-EPMC8196333 | biostudies-literature
| S-EPMC4918828 | biostudies-literature
| S-EPMC4559193 | biostudies-literature
| S-EPMC5355209 | biostudies-other
| S-EPMC4612392 | biostudies-literature